• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超氧化物歧化酶乳膏的局部应用。

Topical application of superoxide dismutase cream.

作者信息

Mizushima Y, Hoshi K, Yanagawa A, Takano K

机构信息

Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.

出版信息

Drugs Exp Clin Res. 1991;17(2):127-31.

PMID:1864227
Abstract

A superoxide dismutase (SOD) cream containing 0.6 mg/ml of bovine SOD was prepared. It was applied locally onto the skin and mucosal lesions caused by progressive systemic sclerosis (PSS), systemic lupus erythematosus (SLE), Behçet's disease, herpes simplex and burns. The lesions and symptoms were rapidly improved in many cases after its administration, even when the symptoms were stabilized for several weeks before the treatment. Although the trial was open-labelled, the topical application of SOD was concluded to be effective for these conditions.

摘要

制备了一种含有0.6毫克/毫升牛超氧化物歧化酶(SOD)的乳膏。将其局部应用于由进行性系统性硬化症(PSS)、系统性红斑狼疮(SLE)、白塞病、单纯疱疹和烧伤引起的皮肤及黏膜损伤处。在给药后,许多病例中的损伤和症状迅速改善,即使在治疗前症状已稳定数周。尽管该试验为开放性标签试验,但得出结论认为SOD局部应用对这些病症有效。

相似文献

1
Topical application of superoxide dismutase cream.超氧化物歧化酶乳膏的局部应用。
Drugs Exp Clin Res. 1991;17(2):127-31.
2
[Preliminary study of the therapeutic effect of superoxide dismutase in 7 cases of Behçet's disease].[超氧化物歧化酶治疗7例白塞病的疗效初步研究]
C R Acad Sci III. 1986;302(7):243-6.
3
Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.喷昔洛韦乳膏局部应用治疗单纯疱疹性面部/唇疱疹:一项随机、双盲、多中心、阿昔洛韦对照试验。
J Dermatolog Treat. 2002 Jun;13(2):67-72. doi: 10.1080/095466302317584412.
4
Pimecrolimus 1% cream for cutaneous lupus erythematosus.用于皮肤型红斑狼疮的1%吡美莫司乳膏。
J Am Acad Dermatol. 2004 Sep;51(3):407-10. doi: 10.1016/j.jaad.2004.01.044.
5
Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
J Rheumatol. 1993 Aug;20(8):1445-6.
6
[Treatment of collagenoses with cytostatic agents].
Vnitr Lek. 1980 Oct;26(10):941-6.
7
[Thalidomide--a new prospective therapy in rheumatology and transplantation].沙利度胺——风湿病学和移植领域一种新的前瞻性治疗方法
Wiad Lek. 2003;56(11-12):574-6.
8
Lipid peroxides and superoxide dismutase (SOD) induction in skin inflammatory diseases, and treatment with SOD preparations.皮肤炎症性疾病中脂质过氧化物和超氧化物歧化酶(SOD)的诱导作用,以及SOD制剂治疗
Dermatologica. 1989;179 Suppl 1:101-6. doi: 10.1159/000248458.
9
[The treatment of collagen diseases].[胶原疾病的治疗]
Internist (Berl). 1980 Nov;21(11):697-701.
10
Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study.脂质体包裹超氧化物歧化酶对人类活性氧相关疾病的影响。一项初步研究。
Free Radic Res Commun. 1985;1(2):137-53. doi: 10.3109/10715768509056547.

引用本文的文献

1
Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases.超氧化物歧化酶1纳米颗粒(纳米SOD1)作为治疗眼部炎症性疾病的潜在药物。
Biomedicines. 2021 Apr 7;9(4):396. doi: 10.3390/biomedicines9040396.
2
Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix.将铜生物活性配合物掺入有机或无机基质中以改善其药理学特性。
Molecules. 2020 Dec 10;25(24):5830. doi: 10.3390/molecules25245830.
3
Inhibition of Protein Glycation by Tiger Milk Mushroom [ (Cooke) Ryvarden] and Search for Potential Anti-diabetic Activity-Related Metabolic Pathways by Genomic and Transcriptomic Data Mining.
虎乳菇[(库克)里瓦尔登]对蛋白质糖基化的抑制作用以及通过基因组和转录组数据挖掘寻找潜在的抗糖尿病活性相关代谢途径。
Front Pharmacol. 2018 Feb 14;9:103. doi: 10.3389/fphar.2018.00103. eCollection 2018.
4
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.用于治疗眼部炎症的超氧化物歧化酶1纳米酶
Oxid Med Cell Longev. 2015;2015:5194239. doi: 10.1155/2016/5194239. Epub 2015 Dec 1.
5
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.继发于系统性硬化症的雷诺现象患者接受伊洛前列素治疗后的抗氧化状态。
Clin Rheumatol. 2007 Sep;26(9):1517-21. doi: 10.1007/s10067-007-0613-2. Epub 2007 Mar 31.